Oatly Group (NASDAQ:OTLY) Insider Martin Fredrik Lind Sells 2,968 Shares of Stock

Oatly Group AB Sponsored ADR (NASDAQ:OTLY) insider Martin Fredrik Lind sold 2,968 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $8.96, for a total transaction of $26,593.28. Following the completion of the transaction, the insider owned 18,088 shares in the company, valued at approximately $162,068.48. The trade was a 14.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oatly Group Price Performance

OTLY stock opened at $8.61 on Thursday. The firm has a market cap of $268.89 million, a price-to-earnings ratio of -1.72 and a beta of 1.85. The company has a quick ratio of 0.32, a current ratio of 0.45 and a debt-to-equity ratio of 43.43. Oatly Group AB Sponsored ADR has a 12-month low of $8.09 and a 12-month high of $18.84. The company’s fifty day simple moving average is $10.84 and its 200 day simple moving average is $11.22.

Oatly Group (NASDAQ:OTLY) last released its earnings results on Thursday, April 30th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.52. Oatly Group had a negative net margin of 17.06% and a negative return on equity of 432.75%. The business had revenue of $228.33 million for the quarter, compared to analyst estimates of $214.61 million. On average, analysts expect that Oatly Group AB Sponsored ADR will post -2.77 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on OTLY shares. Barclays set a $14.00 price target on shares of Oatly Group and gave the company an “overweight” rating in a research note on Tuesday, April 14th. Morgan Stanley set a $12.55 price target on shares of Oatly Group in a research note on Thursday, April 30th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Oatly Group in a report on Friday, March 27th. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Oatly Group presently has a consensus rating of “Hold” and an average price target of $14.64.

Institutional Investors Weigh In On Oatly Group

Several hedge funds and other institutional investors have recently made changes to their positions in OTLY. Performa Ltd US LLC increased its position in shares of Oatly Group by 16.8% during the fourth quarter. Performa Ltd US LLC now owns 10,100 shares of the company’s stock worth $108,000 after acquiring an additional 1,450 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of Oatly Group during the first quarter worth about $133,000. Geode Capital Management LLC bought a new stake in shares of Oatly Group during the second quarter worth about $151,000. R Squared Ltd bought a new stake in shares of Oatly Group during the fourth quarter worth about $155,000. Finally, Van ECK Associates Corp increased its position in shares of Oatly Group by 19.0% during the third quarter. Van ECK Associates Corp now owns 11,001 shares of the company’s stock worth $178,000 after acquiring an additional 1,756 shares in the last quarter. 68.15% of the stock is owned by institutional investors.

About Oatly Group

Oatly Group is a Sweden-based food and beverage company specializing in the development, production and sale of oat-derived dairy alternatives. The company’s product lineup includes oat-based drinks, ice cream, yogurts, spreads and cooking creams, all marketed under the Oatly brand name. By leveraging proprietary processing technology, Oatly extracts the nutritional benefits of oats—such as soluble fiber and plant protein—while delivering taste and texture profiles that closely mimic traditional dairy products.

Founded in 1994 as a spin-off from research at Lund University, Oatly initially focused on exploiting the health and functional benefits of oat beta-glucans.